{"id":"https://openalex.org/W2783479183","doi":"https://doi.org/10.1021/acs.molpharmaceut.7b01000","title":"Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu\u2014An EGFR-Targeted Theranostic for Pancreatic Cancer","display_name":"Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu\u2014An EGFR-Targeted Theranostic for Pancreatic Cancer","publication_year":2018,"publication_date":"2018-01-09","ids":{"openalex":"https://openalex.org/W2783479183","doi":"https://doi.org/10.1021/acs.molpharmaceut.7b01000","mag":"2783479183","pmid":"https://pubmed.ncbi.nlm.nih.gov/29314858"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.7b01000","doi":"https://doi.org/10.1021/acs.molpharmaceut.7b01000","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.7b01000","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051836274","display_name":"Sadaf Aghevlian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sadaf Aghevlian","raw_affiliation_strings":["Department of Pharmaceutical Sciences, University of Toronto, 144 College Street, Toronto, ON M5S 3M2, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Toronto, 144 College Street, Toronto, ON M5S 3M2, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031882165","display_name":"Yijie Lu","orcid":"https://orcid.org/0000-0002-0192-5270","observed_orcids":["https://orcid.org/0000-0002-0192-5270"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Yijie Lu","raw_affiliation_strings":["Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026093276","display_name":"Mitchell A. Winnik","orcid":"https://orcid.org/0000-0002-2673-2141","observed_orcids":["https://orcid.org/0000-0002-2673-2141"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mitchell A. Winnik","raw_affiliation_strings":["Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada"],"raw_orcid":"https://orcid.org/0000-0002-2673-2141","affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011309882","display_name":"David William Hedley","orcid":"https://orcid.org/0000-0003-1323-2655","observed_orcids":["https://orcid.org/0000-0003-1323-2655"]},"institutions":[{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"David W. Hedley","raw_affiliation_strings":["Department of Medical Oncology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2M9, Canada","institution_ids":["https://openalex.org/I2802654988"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023465589","display_name":"Raymond M. Reilly","orcid":"https://orcid.org/0000-0003-1038-7993","observed_orcids":["https://orcid.org/0000-0003-1038-7993"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Raymond M. Reilly","raw_affiliation_strings":["Department of Medical Imaging, University of Toronto, 263 McCaul Street, Toronto, ON M5T 1W7, Canada","Department of Pharmaceutical Sciences, University of Toronto, 144 College Street, Toronto, ON M5S 3M2, Canada","Toronto General Research Institute and Joint Department of Medical Imaging, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada"],"raw_orcid":"https://orcid.org/0000-0003-1038-7993","affiliations":[{"raw_affiliation_string":"Department of Medical Imaging, University of Toronto, 263 McCaul Street, Toronto, ON M5T 1W7, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Toronto, 144 College Street, Toronto, ON M5S 3M2, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Toronto General Research Institute and Joint Department of Medical Imaging, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada","institution_ids":["https://openalex.org/I1325899441"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5023465589"],"corresponding_institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I185261750"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":4.7293,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.96112601,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"15","issue":"3","first_page":"1150","last_page":"1159"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.8920000195503235},{"id":"https://openalex.org/keywords/metal-chelating-polymers","display_name":"metal-chelating polymers","score":0.9169999957084656},{"id":"https://openalex.org/keywords/dota-chelator","display_name":"DOTA chelator","score":0.8759999871253967},{"id":"https://openalex.org/keywords/111in","display_name":"indium-111","score":0.7900000214576721},{"id":"https://openalex.org/keywords/lutetium-177","display_name":"lutetium-177","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/spect-imaging","display_name":"SPECT imaging","score":0.8450000286102295},{"id":"https://openalex.org/keywords/antibody-conjugation","display_name":"antibody conjugation","score":0.5860000252723694},{"id":"https://openalex.org/keywords/hydrazone-bond","display_name":"hydrazone bond","score":0.5180000066757202},{"id":"https://openalex.org/keywords/specific-activity","display_name":"specific activity","score":0.4909999966621399},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.625},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.4189999997615814},{"id":"https://openalex.org/keywords/mda-mb-468-cells","display_name":"MDA-MB-468","score":0.7540000081062317},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.37700000405311584}],"concepts":[{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.9479509592056274},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.8059463500976562},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7681704759597778},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.5580005645751953},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3525911569595337},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.33775240182876587},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3035331964492798},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16771700978279114},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1579645276069641},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.13929104804992676},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.10945367813110352},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10260847210884094},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.0},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068936","descriptor_name":"Theranostic Nanomedicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002614","descriptor_name":"Chelating Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006573","descriptor_name":"Heterocyclic Compounds, 1-Ring","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008187","descriptor_name":"Lutetium","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008187","descriptor_name":"Lutetium","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053768","descriptor_name":"Metal Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.7b01000","doi":"https://doi.org/10.1021/acs.molpharmaceut.7b01000","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.7b01000","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:29314858","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29314858","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311169","display_name":"Cancer Research Society","ror":"https://ror.org/00t38a349"},{"id":"https://openalex.org/F4320321386","display_name":"Terry Fox Foundation","ror":"https://ror.org/05vd00053"},{"id":"https://openalex.org/F4320334576","display_name":"Canadian Cancer Society Research Institute","ror":"https://ror.org/017343w90"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1479786700","https://openalex.org/W1592543887","https://openalex.org/W1965067289","https://openalex.org/W1977703188","https://openalex.org/W1984975142","https://openalex.org/W1985241728","https://openalex.org/W1990522632","https://openalex.org/W1997140899","https://openalex.org/W2002268410","https://openalex.org/W2003868955","https://openalex.org/W2006008435","https://openalex.org/W2007886847","https://openalex.org/W2015232449","https://openalex.org/W2018196946","https://openalex.org/W2039144093","https://openalex.org/W2049706787","https://openalex.org/W2059717684","https://openalex.org/W2075075102","https://openalex.org/W2078356159","https://openalex.org/W2088713834","https://openalex.org/W2116062997","https://openalex.org/W2116547757","https://openalex.org/W2121058401","https://openalex.org/W2165567204","https://openalex.org/W2167157100","https://openalex.org/W2168198903","https://openalex.org/W2218133630","https://openalex.org/W2277880221","https://openalex.org/W2283445440","https://openalex.org/W2290094801","https://openalex.org/W2315587687","https://openalex.org/W2317749882","https://openalex.org/W2318191023","https://openalex.org/W2320653174","https://openalex.org/W2409800999","https://openalex.org/W2416345136","https://openalex.org/W2560018831","https://openalex.org/W2583178166","https://openalex.org/W2742841696","https://openalex.org/W4211120843"],"related_works":["https://openalex.org/W3091744728","https://openalex.org/W2959578610","https://openalex.org/W3104946688","https://openalex.org/W2583178166","https://openalex.org/W2349147526","https://openalex.org/W2420270153","https://openalex.org/W2028333223","https://openalex.org/W7133053312","https://openalex.org/W3190870985","https://openalex.org/W4289793990"],"abstract_inverted_index":{"A":[0],"metal-chelating":[1],"polymer":[2,507],"(MCP)":[3],"with":[4,53,99,109,144,181,293,439,448,464,473,487],"a":[5,78,91,166,188],"polyglutamide":[6],"(PGlu)":[7],"backbone":[8],"presenting":[9],"on":[10,96],"average":[11],"13":[12],"DOTA":[13,176],"(tetraazacyclododecane-1,4,7,10-tetraacetic":[14],"acid)":[15],"chelators":[16],"for":[17,59,82,214,314,321,499,505],"complexing":[18],"111":[19,54,145,182,238,249,259,284,311,323,329,349,353,378,407,415,429,433,465],"In":[20,55,146,183,239,250,260,285,330,341,350,354,408,430,466],"or":[21,61,68,147,184,431,447],"177":[22,57,148,185,199,218,232,241,468],"Lu":[23,58,149,186,200,219,233,242,469],"and":[24,33,56,165,194,240,270,278,351,399,467,479],"10":[25],"polyethylene":[26],"glycol":[27],"(PEG)":[28],"chains":[29],"to":[30,38,137,160,187,204,220,246,265,376,388,444,457],"minimize":[31],"liver":[32,316,501],"spleen":[34],"uptake":[35,281,326,346,366,394,404],"was":[36,86,115,179,226,305,318,334,373,409,496,503],"conjugated":[37,387],"antiepidermal":[39],"growth":[40],"factor":[41],"receptor":[42],"(EGFR)":[43],"monoclonal":[44],"antibody":[45],"(mAb),":[46],"panitumumab.":[47],"Because":[48],"panitumumab-MCP":[49,75,143],"may":[50,391],"be":[51,77],"dual-labeled":[52],"SPECT,":[60],"radioimmunotherapy":[62],"(RIT)":[63],"exploiting":[64],"the":[65,97,120,276,315,396,500,506],"Auger":[66],"electrons":[67],"\u03b2-particle":[69],"emissions,":[70],"respectively,":[71],"we":[72],"propose":[73],"that":[74,151,454],"could":[76],"useful":[79],"theranostic":[80],"agent":[81],"EGFR-positive":[83,294],"PnCa.":[84],"Bioconjugation":[85],"achieved":[87],"by":[88,107,117,357,421],"reaction":[89,108,114],"of":[90,119,142,170,191,216,273,282,327,347,359,367,384,405,427,441],"hydrazine":[92],"nicotinamide":[93],"(HyNIC)":[94],"group":[95],"MCP":[98,390,459],"an":[100,389,458],"aryl":[101],"aromatic":[102],"aldehyde":[103],"introduced":[104],"into":[105,275],"panitumumab":[106,443,456],"succinimidyl-4-formylbenzamide":[110],"(S-4FB).":[111],"The":[112,211,280],"conjugation":[113],"monitored":[116],"measurement":[118],"chromophoric":[121],"bis-aryl":[122],"hydrazone":[123],"bond":[124],"formed":[125],"(\u03b5":[126],"350":[127],"nm":[128],"=":[129],"24":[130],"500":[131],"M":[132],"\u20131":[133,135],"cm":[134],")":[136],"achieve":[138],"two":[139,175],"MCPs/panitumumab.":[140],"Labeling":[141],"demonstrated":[150],"masses":[152],"as":[153,155,257],"small":[154],"0.1":[156],"\u03bcg":[157],"were":[158,243,355,419,436],"labeled":[159,180],">90%":[161],"labeling":[162,463],"efficiency":[163],"(L.E.)":[164],"specific":[167],"activity":[168],"(SA)":[169],">70":[171],"MBq/\u03bcg.":[172],"Panitumumab-DOTA":[173],"incorporating":[174],"per":[177],"mAb":[178],"maximum":[189],"SA":[190,462],"65":[192],"MBq/\u03bcg":[193],"46":[195],"MBq/\u03bcg,":[196],"respectively.":[197],"Panitumumab-MCP-":[198,248],"exhibited":[201,251],"saturable":[202],"binding":[203,215,476],"EGFR-overexpressing":[205],"MDA-MB-468":[206],"human":[207,296,490],"breast":[208],"cancer":[209,298],"cells.":[210],"K":[212],"d":[213],"panitumumab-MCP-":[217,283,322,328,348,377,428],"EGFR":[221,475],"(2.2":[222],"\u00b1":[223,235,332,343,371],"0.6":[224],"nmol/L)":[225],"not":[227,306,335,437],"significantly":[228,307,336,411],"different":[229,308,337],"than":[230,309,338,413,470],"panitumumab-DOTA-":[231,258,310,339,352,406,432],"(1.0":[234],"0.4":[236],"nmol/L).":[237],"stably":[244],"complexed":[245],"panitumumab-MCP.":[247],"similar":[252,375,497],"whole":[253],"body":[254],"retention":[255,400],"(55\u201360%)":[256],"in":[261,286,290,477,483,485],"NOD-scid":[262,291],"mice":[263,292,486],"up":[264],"72":[266,302,424],"h":[267,303,425],"postinjection":[268],"(p.i.)":[269],"equivalent":[271],"excretion":[272],"radioactivity":[274],"urine":[277],"feces.":[279],"most":[287],"normal":[288],"tissues":[289],"PANC-1":[295,417,489],"pancreatic":[297],"(PnCa)":[299],"xenografts":[300],"at":[301,423],"p.i.":[304,426],"In,":[312],"except":[313,498],"which":[317,502],"3-fold":[319],"greater":[320],"In.":[324,379,416,434],"Tumor":[325,345,365,403],"(6.9":[331],"1.3%ID/g)":[333],"11":[340],"(6.6":[342],"3.3%ID/g).":[344],"reduced":[356],"preadministration":[358,440],"excess":[360,442],"panitumumab,":[361,472],"suggesting":[362],"EGFR-mediated":[363],"uptake.":[364],"nonspecific":[368,449],"IgG-MCP":[369],"(5.4":[370],"0.3%ID/g)":[372],"unexpectedly":[374],"An":[380],"increased":[381],"hydrodynamic":[382],"radius":[383],"IgG":[385,450],"when":[386],"encourage":[392],"tumor":[393,481],"via":[395],"enhanced":[397],"permeability":[398],"(EPR)":[401],"effect.":[402],"3.5-fold":[410],"higher":[412,461,504],"IgG-DOTA-":[414],"tumors":[418],"imaged":[420],"microSPECT/CT":[422],"Tumors":[435],"visualized":[438],"block":[445],"EGFR,":[446],"radioimmunoconjugates.":[451,508],"We":[452],"conclude":[453],"linking":[455],"enabled":[460],"DOTA-conjugated":[471],"preserved":[474],"vitro":[478],"comparable":[480],"localization":[482],"vivo":[484],"s.c.":[488],"PnCa":[491],"xenografts.":[492],"Normal":[493],"tissue":[494],"distribution":[495]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-01-26T00:00:00"}